DE60217102D1 - Verbesserungen der diagnose des akuten myokardinfarkts und anderer klinischer zustände - Google Patents

Verbesserungen der diagnose des akuten myokardinfarkts und anderer klinischer zustände

Info

Publication number
DE60217102D1
DE60217102D1 DE60217102T DE60217102T DE60217102D1 DE 60217102 D1 DE60217102 D1 DE 60217102D1 DE 60217102 T DE60217102 T DE 60217102T DE 60217102 T DE60217102 T DE 60217102T DE 60217102 D1 DE60217102 D1 DE 60217102D1
Authority
DE
Germany
Prior art keywords
clinical event
molecule
modified
blood
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60217102T
Other languages
English (en)
Other versions
DE60217102T2 (de
Inventor
A Crosby
L Morris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ischemia Technologies Inc
Original Assignee
Ischemia Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ischemia Technologies Inc filed Critical Ischemia Technologies Inc
Application granted granted Critical
Publication of DE60217102D1 publication Critical patent/DE60217102D1/de
Publication of DE60217102T2 publication Critical patent/DE60217102T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6827—Total protein determination, e.g. albumin in urine
    • G01N33/683—Total protein determination, e.g. albumin in urine involving metal ions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Peptides Or Proteins (AREA)
DE60217102T 2001-05-04 2002-04-30 Verbesserungen der diagnose des akuten myokardinfarkts und anderer klinischer zustände Expired - Fee Related DE60217102T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84995601A 2001-05-04 2001-05-04
US849956 2001-05-04
PCT/US2002/013906 WO2002089656A2 (en) 2001-05-04 2002-04-30 Diagnosis of acute myocardial infarction

Publications (2)

Publication Number Publication Date
DE60217102D1 true DE60217102D1 (de) 2007-02-08
DE60217102T2 DE60217102T2 (de) 2007-06-28

Family

ID=25306922

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60217102T Expired - Fee Related DE60217102T2 (de) 2001-05-04 2002-04-30 Verbesserungen der diagnose des akuten myokardinfarkts und anderer klinischer zustände

Country Status (7)

Country Link
EP (1) EP1392150B1 (de)
JP (1) JP2004529351A (de)
AT (1) ATE349181T1 (de)
AU (1) AU2002305335B2 (de)
CA (1) CA2446187A1 (de)
DE (1) DE60217102T2 (de)
WO (1) WO2002089656A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7262017B2 (en) 2001-09-14 2007-08-28 Torrey Pines Institute For Molecular Studies Diagnostic markers for ischemia
JP2005510712A (ja) 2001-11-26 2005-04-21 イスケミア・テクノロジーズ・インコーポレーテッド 虚血の電気化学的検知
US7074194B2 (en) 2003-05-19 2006-07-11 Ischemia Technologies, Inc. Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin
AU2005227312B2 (en) 2004-03-22 2011-04-07 Ffa Sciences, Llp Development and use of fluorescent probes of unbound analytes
CA2568976A1 (en) * 2004-06-03 2005-12-22 Ciphergen Biosystems, Inc. Biomarkers for peripheral artery disease
ES2342394T3 (es) 2004-07-23 2010-07-06 Centre De Recherche Public De La Sante Supervision de la insuficiencia cardiaca.
GB2435328B (en) * 2006-02-15 2010-04-28 Inverness Medical Switzerland Methods and device for indirectly detecting the presence of an analyte
WO2008060841A2 (en) 2006-10-27 2008-05-22 Ffa Sciences, Llc Use of probes for unbound metabolites
SE532103C2 (sv) * 2006-12-12 2009-10-27 Knut Johansen Metod för att bestämma hälsostatus från analyter i vätskeprover
WO2008075193A2 (en) * 2006-12-19 2008-06-26 Inverness Medical Switzerland Gmbh Assay devices and methods
WO2009115756A2 (fr) * 2008-03-14 2009-09-24 bioMérieux Procede de detection directe de l'albumine modifiee de l'ischemie par utilisation d'un partenaire de liaison a un derive aldehyde issu de la peroxydation de lipides sous forme liee
CN103558398B (zh) * 2013-11-04 2015-06-17 山东博科生物产业有限公司 一种抗肝素干扰的缺血修饰白蛋白检测试剂
US20180284134A1 (en) * 2015-09-24 2018-10-04 Cmc Consulting Boston, Inc. Detection of acute myocardial infarction
CN109754877B (zh) * 2018-01-23 2023-12-22 上海移视网络科技有限公司 一种基于人工智能的十二导联标准心电图急性心肌梗死智能判别系统
CN112180013B (zh) * 2020-09-29 2022-11-15 上海脉示生物技术有限公司 用于心肌梗死诊断的肠道微生物代谢标志物组合物及其检测方法和应用
CN116930512B (zh) * 2023-09-19 2024-01-05 细胞生态海河实验室 一种用于脑卒中再发风险分析的生物标志物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710008B1 (en) * 1990-10-12 1999-09-07 Spectral Diagnostics Inc Method and device for diagnosing and distinguishing chest pain in early onset thereof
WO2000020840A1 (en) * 1998-10-02 2000-04-13 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
CA2263063C (en) * 1999-02-26 2004-08-10 Skye Pharmatech Incorporated Method for diagnosing and distinguishing stroke and diagnostic devices for use therein

Also Published As

Publication number Publication date
EP1392150A2 (de) 2004-03-03
EP1392150B1 (de) 2006-12-27
AU2002305335B2 (en) 2008-02-14
ATE349181T1 (de) 2007-01-15
EP1392150A4 (de) 2004-11-03
WO2002089656A2 (en) 2002-11-14
JP2004529351A (ja) 2004-09-24
DE60217102T2 (de) 2007-06-28
CA2446187A1 (en) 2002-11-14
WO2002089656A3 (en) 2003-07-24

Similar Documents

Publication Publication Date Title
DE60217102D1 (de) Verbesserungen der diagnose des akuten myokardinfarkts und anderer klinischer zustände
Chien et al. Quantitative pathology of cutaneous nerve terminal degeneration in the human skin
DE69905310D1 (de) Reflexalgorithmus zur frühen und kostengünstigen Diagnose von myokardischen Infarkten geeignet für automatisierte diagnostische Plattformen
BRPI0112262B8 (pt) processo para detecção e teste para um marcador de uma doença conformacional, kit, processo para identificar um composto, processo para detectar a presença de uma forma patogênica prp sc de proteína de príon, e aparelho
He et al. Label-free electrochemical monitoring of vasopressin in aptamer-based microfluidic biosensors
TW200600060A (en) Apparatus for the manufacture of medical devices
DE60030915D1 (de) Vektorabbildung für eine dreidimensionale Rekonstruktion von inneren Organen
KR930022086A (ko) 아밀로이드 전구체 단백질의 단백질가수분해에 근거한 알츠하이머병(Alzheimer's disease)의 진단분석
ATE427489T1 (de) Diagnostische marker fur ischamie und mortalitatsrisiken
DE60333608D1 (de) Biomarker zur Diagnose von Alzheimer
ATE375517T1 (de) Diagnosestellung von akuten myokardialen, ischämischen erkrankungen durch kombination von markern
DE602004011553D1 (de) Hemmer-darstellende mittel
DE50103907D1 (de) Verwendungen der Aldose-1-Epimerase (Mutarotase) für die Diagnose von Entzündungserkrankungen und Sepsis
BRPI0512948A (pt) biomarcadores de mal de alzheimer
US20210405038A1 (en) Development and parameter assessment for vertically aligned platinum wire aptasensor arrays for impedimetric detection of cardiac biomarkers
Laurino et al. Comparative sensitivities and specificities of the mass measurements of CK-MB2, CK-MB, and myoglobin for diagnosing acute myocardial infarction
BR9910009A (pt) Processos para coletar uma amostra derivada de um material fecal e para a detencção de sangue oculto em material fecal, e, kit de ensaio para teste de material fecal
Gupta et al. Diagnosis of acute myocardial infarction: CK-MB versus cTn-T in Indian patients
ATE309542T1 (de) Verwendung der glycin-n-acyl-transferase (gnat) für die diagnose von entzündungserkrankungen und sepsis
DE60229223D1 (de) Screening-verfahren für den prädiabetiszustand und screening-reagenz
EP1856645A2 (de) Targets zur erkennung von ischämie
BR0317404A (pt) Variantes do fator xiia
Eisenschenk et al. Proximal myotonic myopathy: clinical, neuropathologic, and molecular genetic features
Sikkander et al. Exigency for Use of Nano Material Biosensors In Diagnosis of Disease
KR950009257A (ko) 골다공증 진단제

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8380 Miscellaneous part iii

Free format text: PFANDRECHT

8339 Ceased/non-payment of the annual fee